Water Processor Assembly Research Articles

Biofilm formation is correlated with low nutrient and simulated microgravity conditions in a Burkholderia isolate from the ISS water processor assembly

The International Space Station (ISS) Water Processor Assembly (WPA) experiences intermittent dormancy in the WPA wastewater tank during water recycling events which promotes biofilm formation within the system. In this work we aimed to gain a deeper understanding of the impact of nutrient limitation on bacterial growth and biofilm formation under microgravity in support of biofilm mitigation efforts in exploration water recovery systems. A representative species of bacteria that is commonly cultured from the ISS WPA was cultured in an WPA influent water ersatz formulation tailored for microbiological studies. An isolate of Burkholderia contaminans was cultured under a simulated microgravity (SμG) treatment in a vertically rotating high-aspect rotating vessel (HARV) to create the low shear modeled microgravity (LSMMG) environment on a rotating wall vessel (RWV), with a rotating control (R) in the horizontal plane at the predetermined optimal rotation per minute (rpm) speed of 20. Over the course of the growth curve, the bacterial culture in ersatz media was harvested for bacterial counts, and transcriptomic and nutrient content analyses. The cultures under SμG treatment showed a transcriptomic signature indicative of nutrient stress and biofilm formation as compared to the R control treatment. Further analysis of the WPA ersatz over the course of the growth curve suggests that the essential nutrients of the media were consumed faster in the early stages of growth for the SμG treatment and thus approached a nutrient limited growth condition earlier than in the R control culture. The observed limited nutrient response may serve as one element to explain a moderate enhancement of adherent biofilm formation in the SμG treatment after 24 h. While nutrients levels can be modulated, one implication of this investigation is that biofilm mitigation in the ISS environment could benefit from methods such as mixing or the maintenance of minimum flow within a dormant water system in order to force convection and offset the response of microbes to the secondary effects of microgravity.

Genome Sequences of Three Common Bacterial Isolates from Wastewater from the Water Processor Assembly at the International Space Station.

Bacteria from the genera Burkholderia, Ralstonia, and Methylobacterium were consistently detected in water of the life support systems at the International Space Station. Here, we report complete genomes of recent isolates that are representative of these genera to support future studies in biofilm and wastewater treatment in space habitats.

Preparation for and performance of a Pseudomonas aeruginosa biofilm experiment on board the International Space Station

Biofilms are problematic on Earth due to their ability to both degrade the materials upon which they grow and promote infections. Remarkably, 65% of infections and 80% of chronic diseases on Earth are associated with biofilms. The impact of biofilms is even greater in space, as the crew's lives and mission success depend on nominal operation of mechanical systems which can be interrupted by material damage associated with biofilm growth. Furthermore, the isolated confined environment nature of spaceflight may increase the rates of disease transmission. In the case of the International Space Station (ISS), biofilms are an identified problem on the Environmental Control and Life Support System (ECLSS), namely on the water processor assembly (WPA). In late 2019, the bacterial component of the Space Biofilms experiment launched to ISS to (i) characterize the mass, thickness, morphology, and gene expression of biofilms formed in space compared to matched Earth controls, (ii) interrogate the expression of antimicrobial resistance genes, and (iii) test novel materials as potential biofilm control strategies for future ECLSS components. For this, 288 bacterial samples were prepared prior to the launch of the Northrop Grumman CRS-12 mission from NASA's Wallops Flight Facility. The samples were integrated into the spaceflight hardware, BioServe's Fluid Processing Apparatus (FPA), packed in sets of eight in Group Activation Packs (GAP). Half of these samples were activated and terminated on orbit by NASA astronauts Jessica Meir and Christina Koch, while the remaining half were processed equivalently on Earth. The spaceflight bacterial samples of Space Biofilms returned on board the SpaceX CRS-19 Dragon spacecraft in early 2020. We here describe the test campaign implemented to verify the experiment design and confirm it would enable us to achieve the project's scientific goals. This campaign ended with the Experiment Verification Test (EVT), from which we present example morphology and transcriptomic results. We describe in detail the sample preparation prior to flight, including cleaning and sterilization of the coupons of six materials (SS316, passivated-SS316, lubricant impregnated surface, catheter-grade silicone with and without a microtopography, and cellulose membrane), loading and integration of growth media, bacterial inoculum, and the fixative and preservative to enable experiment termination on orbit. Additionally, we describe the performance of the experiment on board the ISS, including crew activities, use of assets, temperature profile, and experiment timeline; all leading to a successful spaceflight experiment. Hence, this manuscript focuses on the steps implemented to ensure the experiment would be ready for spaceflight, as well as ISS and ground operations, with results presented elsewhere. The processes discussed here may serve as a guideline to teams planning their own gravitational microbiology experiments. This material is based upon work supported by the National Aeronautics and Space Administration under Grant No. 80NSSC17K0036.

Urine Treatment on the International Space Station: Current Practice and Novel Approaches.

A reliable, robust, and resilient water recovery system is of paramount importance on board the International Space Station (ISS). Such a system must be able to treat all sources of water, thereby reducing resupply costs and allowing for longer-term space missions. As such, technologies able to dewater urine in microgravity have been investigated by different space agencies. However, despite over 50 years of research and advancements on water extraction from human urine, the Urine Processing Assembly (UPA) and the Water Processor Assembly (WPA) now operating on the ISS still achieve suboptimal water recovery rates and require periodic consumables resupply. Additionally, urine brine from the treatment is collected for disposal and not yet reused. These factors, combined with the need for a life support system capable of tolerating even dormant periods of up to one year, make the research in this field ever more critical. As such, in the last decade, extensive research was conducted on the adaptation of existing or emerging technologies for the ISS context. In virtue of having a strong chemical resistance, small footprint, tuneable selectivity and versatility, novel membrane-based processes have been in focus for treating human urine. Their hybridisation with thermal and biological processes as well as the combination with new nanomaterials have been particularly investigated. This article critically reviews the UPA and WPA processes currently in operation on the ISS, summarising the research directions and needs, highlighted by major space agencies, necessary for allowing life support for missions outside the Low Earth Orbit (LEO). Additionally, it reviews the technologies recently proposed to improve the performance of the system as well as new concepts to allow for the valorisation of the nutrients in urine or the brine after urine dewatering.